(VIANEWS) – IMMO MOURY (IMMOU.BR), SANOFI (SAN.PA), KPN KON (KPN.AS) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio at the moment. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. IMMO MOURY (IMMOU.BR)
188.61% Payout Ratio
Immo Moury SCA is a real estate investment trust. Immo Moury SCA is based in Belgium.
Earnings Per Share
As for profitability, IMMO MOURY has a trailing twelve months EPS of €0.95.
PE Ratio
IMMO MOURY has a trailing twelve months price to earnings ratio of 32. Meaning, the purchaser of the share is investing €32 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.71%.
Yearly Top and Bottom Value
IMMO MOURY’s stock is valued at €30.40 at 07:10 EST, way under its 52-week high of €39.80 and way higher than its 52-week low of €27.20.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Oct 13, 2023, the estimated forward annual dividend rate is 1.8 and the estimated forward annual dividend yield is 5.92%.
Volume
Today’s last reported volume for IMMO MOURY is 40 which is 70.58% below its average volume of 136.
More news about IMMO MOURY.
2. SANOFI (SAN.PA)
98.61% Payout Ratio
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €4.3.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 13, 2024, the estimated forward annual dividend rate is 3.76 and the estimated forward annual dividend yield is 3.98%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 2.3%, now sitting on 46.29B for the twelve trailing months.
Moving Average
SANOFI’s value is above its 50-day moving average of €90.40 and higher than its 200-day moving average of €90.04.
More news about SANOFI.
3. KPN KON (KPN.AS)
69.42% Payout Ratio
Koninklijke KPN N.V. provides telecommunications and information technology (IT) services in the Netherlands. It operates through Consumer; Business; Wholesale; and Network, Operations & IT segments. The company offers fixed and mobile telephony, fixed and mobile broadband internet, and television services to retail and business consumers; infrastructure and network related IT solutions to business customers; and wholesale network services to third parties. It also provides IT services, including cloud, workspace, and cybersecurity services; interconnect traffic, visitor roaming, and digital products; and NL-ix, an interconnect exchange, as well as sells handsets, peripheral equipment, and software licenses. In addition, the company offers virus and malware scanners; anti-virus licenses; 1Password, a password management tool; DNSSEC, a technology that prevents customers from being led to fake websites; KPN Veilig Netwerk Thuis, a smart network security; Censornet, which includes web security, cloud application security broker, email protection, and awareness training; SuperVision, which provides digital governance solutions for workspaces; and OneMonitoring to ensure early detection of cyber incidents. Further, it provides fiber networks; and IT services for integrating healthcare systems and optimizing communication between healthcare providers. The company distributes its products and services under the KPN, XS4ALL, Simyo, KPN Security, KPN Health, Solcon, Inspark, and KPN Partner Network brands. The company was formerly known as Koninklijke PTT Nederland NV and changed its name to Koninklijke KPN N.V. in June 1998. Koninklijke KPN N.V. was founded in 1881 and is headquartered in Rotterdam, the Netherlands.
Earnings Per Share
As for profitability, KPN KON has a trailing twelve months EPS of €0.21.
PE Ratio
KPN KON has a trailing twelve months price to earnings ratio of 17.9. Meaning, the purchaser of the share is investing €17.9 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.12%.
More news about KPN KON.
4. KBC (KBC.BR)
56.21% Payout Ratio
KBC Group NV, together with its subsidiaries, provides integrated bank-insurance services primarily for retail, private banking, small and medium sized enterprises, and mid-cap clients. The company provides demand deposits and savings accounts; home and mortgage loans; consumer finance and SME funding services; credit, investment fund and asset management, and life and non-life insurance; and cash management, payments, trade finance, lease, money market, capital market products, and stockbroking services. It offers digital and mobile banking services. The company was formerly known as KBC Bank and Insurance Holding Company NV and changed its name to KBC Group NV in March 2005. KBC Group NV was incorporated in 1935 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, KBC has a trailing twelve months EPS of €7.12.
PE Ratio
KBC has a trailing twelve months price to earnings ratio of 9.49. Meaning, the purchaser of the share is investing €9.49 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.86%.
Moving Average
KBC’s value is higher than its 50-day moving average of €67.36 and higher than its 200-day moving average of €62.31.
Yearly Top and Bottom Value
KBC’s stock is valued at €67.60 at 07:10 EST, under its 52-week high of €71.70 and way above its 52-week low of €48.78.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 7.9% and positive 8.2% for the next.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 27, 2024, the estimated forward annual dividend rate is 4.15 and the estimated forward annual dividend yield is 6.07%.
More news about KBC.
5. SPAREBANKEN VEST (SVEG.OL)
53.5% Payout Ratio
Sparebanken Vest, a financial services company, provides banking and financing services in the counties of Vestland and Rogaland, Norway. The company operates through Corporate Market, Retail Market, Bulder Bank, Treasury, and Estate Agency Activities segments. It is also involved in home mortgage activities. Sparebanken Vest was founded in 1823 and is headquartered in Bergen, Norway.
Earnings Per Share
As for profitability, SPAREBANKEN VEST has a trailing twelve months EPS of kr14.02.
PE Ratio
SPAREBANKEN VEST has a trailing twelve months price to earnings ratio of 9.37. Meaning, the purchaser of the share is investing kr9.37 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.74%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 22, 2024, the estimated forward annual dividend rate is 7.5 and the estimated forward annual dividend yield is 5.75%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 24.3% and 10.7%, respectively.
Volume
Today’s last reported volume for SPAREBANKEN VEST is 20271 which is 71.69% below its average volume of 71627.
More news about SPAREBANKEN VEST.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 1% and 1%, respectively.
Volatility
1’s last week, last month’s, and last quarter’s current intraday variation average was 1.00%, 1.00%, and 1.00%.
1’s highest amplitude of average volatility was 1.00% (last week), 1.00% (last month), and 1.00% (last quarter).
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 1%.
More news about 1.
